These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24716406)

  • 21. Catechol metabolites of polychlorinated biphenyls inhibit the catechol-O-methyltransferase-mediated metabolism of catechol estrogens.
    Garner CE; Burka LT; Etheridge AE; Matthews HB
    Toxicol Appl Pharmacol; 2000 Jan; 162(2):115-23. PubMed ID: 10637135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chemistry of catechol-O-methyltransferase inhibitors.
    Learmonth DA; Kiss LE; Soares-da-Silva P
    Int Rev Neurobiol; 2010; 95():119-62. PubMed ID: 21095461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation.
    Goodman JE; Jensen LT; He P; Yager JD
    Pharmacogenetics; 2002 Oct; 12(7):517-28. PubMed ID: 12360102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of a long-acting, peripherally selective inhibitor of catechol-O-methyltransferase.
    Kiss LE; Ferreira HS; Torrão L; Bonifácio MJ; Palma PN; Soares-da-Silva P; Learmonth DA
    J Med Chem; 2010 Apr; 53(8):3396-411. PubMed ID: 20334432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and evaluation of 3-hydroxypyridin-4-ones as inhibitors of catechol-O-methyltransferase.
    de Beer J; Petzer JP; Lourens ACU; Petzer A
    Mol Divers; 2021 May; 25(2):753-762. PubMed ID: 32108308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medicinal chemistry of catechol O-methyltransferase (COMT) inhibitors and their therapeutic utility.
    Kiss LE; Soares-da-Silva P
    J Med Chem; 2014 Nov; 57(21):8692-717. PubMed ID: 25080080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analgesic activity of myricetin isolated from Myrica rubra Sieb. et Zucc. leaves.
    Tong Y; Zhou XM; Wang SJ; Yang Y; Cao YL
    Arch Pharm Res; 2009 Apr; 32(4):527-33. PubMed ID: 19407970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
    Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
    Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bisubstrate inhibitors of the enzyme catechol O-methyltransferase (COMT): efficient inhibition despite the lack of a nitro group.
    Paulini R; Lerner C; Jakob-Roetne R; Zürcher G; Borroni E; Diederich F
    Chembiochem; 2004 Sep; 5(9):1270-4. PubMed ID: 15368579
    [No Abstract]   [Full Text] [Related]  

  • 30. Synergistic inhibition of lung cancer cell lines by (-)-epigallocatechin-3-gallate in combination with clinically used nitrocatechol inhibitors of catechol-O-methyltransferase.
    Forester SC; Lambert JD
    Carcinogenesis; 2014 Feb; 35(2):365-72. PubMed ID: 24148818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Entacapone, a catechol-O-methyltransferase inhibitor, improves the motor activity and dopamine content of basal ganglia in a rat model of Parkinson's disease induced by Japanese encephalitis virus.
    Hamaue N; Ogata A; Terado M; Tsuchida S; Yabe I; Sasaki H; Hirafuji M; Togashi H; Aoki T
    Brain Res; 2010 Jan; 1309():110-5. PubMed ID: 19879254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biotransformation of baicalin to baicalein significantly strengthens the inhibition potential towards UDP-glucuronosyltransferases (UGTs) isoforms.
    Teng Y; Nian H; Zhao H; Chen P; Wang G
    Pharmazie; 2013 Sep; 68(9):763-7. PubMed ID: 24147345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme.
    Lotta T; Vidgren J; Tilgmann C; Ulmanen I; Melén K; Julkunen I; Taskinen J
    Biochemistry; 1995 Apr; 34(13):4202-10. PubMed ID: 7703232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospecting for new catechol-
    da Silva IR; Parise MR; Pereira M; da Silva RA
    J Biomol Struct Dyn; 2021 Oct; 39(16):5872-5891. PubMed ID: 32691671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed O-methylation of l-DOPA in MB-COMT-deficient mice after oral administration of l-DOPA and carbidopa.
    Tammimäki A; Aonurm-Helm A; Männistö PT
    Xenobiotica; 2018 Apr; 48(4):325-331. PubMed ID: 28375049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of 3',4'-dihydroxy-2-methyl-propriophenone (U-0521) on catechol-O-methyltransferase activity and on DOPA accumulation in rat red blood cells and corpus striatum.
    Reches A; Jiang D; Fahn S
    Biochem Pharmacol; 1982 Nov; 31(21):3415-8. PubMed ID: 7150363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms controlling the rate and specificity of catechol O-methylation by human soluble catechol O-methyltransferase.
    Lautala P; Ulmanen I; Taskinen J
    Mol Pharmacol; 2001 Feb; 59(2):393-402. PubMed ID: 11160877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics and crystal structure of catechol-o-methyltransferase complex with co-substrate and a novel inhibitor with potential therapeutic application.
    Bonifácio MJ; Archer M; Rodrigues ML; Matias PM; Learmonth DA; Carrondo MA; Soares-Da-Silva P
    Mol Pharmacol; 2002 Oct; 62(4):795-805. PubMed ID: 12237326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of Cyclic Amidohydrolases.
    Huang CY
    PLoS One; 2015; 10(5):e0127634. PubMed ID: 25993634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of L-Dopa related hyperhomocysteinemia: catechol-O-methyltransferase (COMT) inhibitors or B vitamins? Results from a review.
    Zoccolella S; Iliceto G; deMari M; Livrea P; Lamberti P
    Clin Chem Lab Med; 2007; 45(12):1607-13. PubMed ID: 17963454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.